Families affected by the condition and a dedicated support crew walked 92km across Perth over four days to raise funds and awareness for Duchenne muscular dystrophy.

ST. LOUIS — On a cloudy morning in Forest Park, families gathered not just to take steps together but to take them for each other. The Muscular Dystrophy Association's 2025 Muscle Walk on May 4 drew ...

Muscular dystrophy, known as DMD, is a rare and fatal genetic disease that primarily affects boys, slowly robbing them of their ability to walk, breathe and live independently. Until now, there have ...

Friends and family of Sophie Hutchison, who was diagnosed with limb girdle muscular dystrophy at 13, will take part in this ...

Genethon, a pioneer and leader in gene therapy for rare diseases, unveiled results at the MDA Conference in Orlando confirming the long-term efficacy of its GNT0004 gene therapy in Duchenne muscular ...

PHOENIX (AZFamily) —As we head toward the new year, the medical advances just keep coming for the muscular dystrophy community. New treatments and therapies are being approved to help families ...

The Ironman In You project aims to raise awareness on muscular dystrophy It also aims to raise money for members of the Muscular Dystrophy Association of Singapore As of June 25, this project had ...

Duchenne muscular dystrophy (DMD) is a genetic condition caused by a change, or mutation, in the DMD gene. This gene normally tells the body how to make dystrophin, a protein that helps protect ...

Sophie Hutchison’s condition means she she struggles with 'simple' tasks such as climbing stairs or even lifting her arms.

Atamyo Therapeutics, a biotechnology company specializing in the development of next-generation gene therapies for limb-girdle muscular dystrophy (LGMD), announced at the MDA (Muscular Dystrophy ...